Navigation Links
The Epilepsy Drug Market Will Remain Relatively Flat Through 2019 as Generic Erosion, Especially Within the Second-Generation Antiepileptic Drug Class, is Offset by the Launch of New Therapies
Date:10/21/2010

BURLINGTON, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, over the next decade, the epilepsy drug market will remain relatively flat, increasing from $2.8 billion in 2009 to $2.9 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

The Pharmacor 2010 findings from the topic entitled Epilepsy forecast a decline in overall sales through 2014 due to generic erosion, specifically within the second-generation antiepileptic drug (AED) class, which will lose approximately $400 million by 2014. Generic erosion within the epilepsy market remains relatively conservative but several popular second-generation AEDs will contend with strong generic competition over the next several years. Nevertheless, the market will recover as a result of uptake of both currently-marketed and emerging higher-priced third-generation AEDs.

"Through 2019, the majority of AEDs will be generically available, creating negative pressure on market growth," said Decision Resources Analyst Nadja Rozovsky, Ph.D. "However, emerging agents, combined with greater uptake of the already-available and mostly branded third-generation AEDs, will temper the impact of generic AEDs, and the market will recover by 2019."

The findings reveal that levetiracetam (UCB's Keppra/Keppra XR, generics) is the current market leader in epilepsy. Driven by its preferred use as both a first-line adjunctive therapy and increasingly as first-line monotherapy, levetiracetam will continue to lead the market in 2019 with approximately $540 million in major-market sales.

The continued uptake of current third-generation AEDs—particularly UCB's Vimpat and Sunovion/Bial/Eisai's Zebinix—and uptake of the emerging AEDs UCB's Rikelta, Valeant/GlaxoSmithKline's Potiga and Eisai's perampanel will offer alternative '/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Cyberonics Announces Epilepsy Technology Agreements
2. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
3. Catalyst Pharmaceutical Partners to Present Today at 2010 Epilepsy Pipeline Update Conference
4. Catalyst Pharmaceutical Partners Selected to Present at Epilepsy Conference Highlighting New and Promising Therapies
5. FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
6. Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy
7. The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
8. Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment
9. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
10. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
11. Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... -- With herbal medicines relied upon by consumers worldwide, ... Convention (USP) will provide freely available public standards to ... in these products. Today, USP proposes the first 23 ... Medicines Compendium ( HMC ) for comment by ... . HMC will provide standards for herbal ...
(Date:5/18/2013)... May 18, 2013 Although colonoscopy exams prevent ... the most sensitive method for detecting colorectal cancers 2 ... cancer cases 3 . EndoChoice ® Inc. today ... significantly improves the accuracy of this procedure and greatly ... will be discussing these clinical trial results and featuring ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Statistical Challenges in Medical Device Trail Evaluation 2
... 7, 2011 Rochester Medical Corporation (NASDAQ: ... the previously announced purchase of Laprolan B.V., the former ... BioSciences N.V. Under the terms of the purchase agreement ...  For more information regarding this transaction please refer to ...
... April 7, 2011 Ascension Orthopedics, Inc., a world ... the TITAN Modular Total Shoulder.  The surgeries were performed ... Baltimore, MD.     "I have been ... of years in my practice. Now that Ascension has ...
Cached Medicine Technology:Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
(Date:5/20/2013)... Hospital emergency departments play a growing role in the ... of hospital admissions and serving increasingly as an advanced ... new RAND Corporation study. , While often targeted as ... rooms remain an important safety net for Americans who ... in slowing the growth of health care costs, according ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
(Date:5/20/2013)... As high schoolers prepare for final exams, teens ... -- a prescription stimulant or amphetamine -- to gain ... poll shows only one in 100 parents of teens ... a study drug., Study drugs refer to stimulant medications ... disorder (ADHD); commonly prescribed medicines in this category include ...
Breaking Medicine News(10 mins):Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2
... Kids treated more than 150 days after an Anterior Cruciate ... including medial meniscal tears, say researchers presenting at the American ... Francisco, CA. "In our research, children who had delayed ... to have an increased chance of also having a medial ...
... FRANCISCO, CA When it comes to treating people ... with the use of magnetic resonance images (MRI), according ... Society for Sports Medicine,s (AOSSM) Specialty Day in San ... sample of volunteers without any hip pain, and discovered ...
... appeared to not affect injury rates and performance in ... Orthopaedic Society for Sports Medicine,s Specialty Day in San ... an injury and enhanced performance in baseball pitchers is ... Carl W. Nissen, MD of Elite Sports Medicine and ...
... (HealthDay News) -- ,There,s little evidence linking disease severity ... in HIV-positive children and teens infected around the time ... experts were concerned that more severe HIV illness -- ... specific highly active antiretroviral therapy regimens might increase the ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, Feb. ... ago that a strange new strain of flu first appeared ... States and eventually much of the globe. The H1N1 ... it proved particularly dangerous to children and younger adults -- ...
... Dentistry at the University of Alberta is hoping its latest ... that target certain types of cancers. , The discovery ... fellow Nicolas Coquelle has shed light on what happens in ... a DNA repair enzyme called polynucleotide kinase/phosphatase, or PNKP. This ...
Cached Medicine News:Health News:Delaying ACL reconstruction in kids may lead to higher rates of associated knee injuries 2Health News:HIV Severity, Treatment Unrelated to Kids' Mental Woes: Study 2Health News:H1N1 'Swine' Flu Makes a Comeback in Mexico 2Health News:New understanding of DNA repair could eventually lead to cancer therapy 2
... is an automated microplate analyzer ... microplate techniques. Open architecture design ... many manufacturers' microplate assays and ... R.I.A. and I.F.A. methods as ...
... MAP D-Type can combine a number ... 180 microplates on a simple to ... instrument is a multifunctional stand-alone device ... larger robotic systems. Custom and standard ...
... provides a fast, accurate assessment of,patient ... patented,state-of-the-art optics yield accurate measurements of ... total hemoglobin. When,used in combination with ... gives a comprehensive and complete assessment ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Medicine Products: